ESC Premium Access

FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes

Presentation

About the speaker

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)
19 presentations
0 follower

5 more presentations in this session

FIGARO-DKD - Discussant review.

Speaker: Doctor K. Damman (Groningen, NL)

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes

Speaker: Professor G. Filippatos (Athens, GR)

Thumbnail

FIDELITY Analysis - Discussant review.

Speaker: Professor C. Baigent (Oxford, GB)

Thumbnail

FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Thumbnail

Access the full session

Hot Line - FIGARO-DKD / FIDELITY Analysis

Speakers: Professor B. Pitt, Doctor K. Damman, Professor G. Filippatos, Professor C. Baigent
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ACVC Premium Access

Pharmacological treatment: how to choose your drug (if any)

19 March 2022

Open Access

A curated selection of highlights

24 October 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk